Skip to main content

Want a detailed portfolio tracker?

Prime Medicine (PRME) P/E (2022 - 2026)

Prime Medicine (PRME) P/E from Oct 20, 2022 to Jul 21, 2026. The TTM Prime Medicine (PRME) P/E is -2.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Prime Medicine (PRME)

YearP/EChange
2026-2.60-0.81%
2025-2.62+40.63%
2024-1.87-62.81%
2023-5.02+48.99%
2022-3.37N/A

Comparison Prime Medicine (PRME) P/E with competitors

Prime Medicine (PRME) P/E is -2.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.17%
ENLVEnlivex Ltd0.07-102.87%
FGENFibroGen Inc0.24-109.22%
CHRSCoherus Biosciences Inc0.85-132.60%
FBIOFortress Biotech Inc0.95-136.46%
ORMPOramed Pharmaceuticals Inc1.50-157.75%
AGENAgenus Inc3.01-215.63%
INVAInnoviva Inc3.15-221.18%
VXRTVaxart Inc3.55-236.38%
CRMDCorMedix Inc3.63-239.41%
CVACCureVac N.V.4.45-270.81%
GLPGGalapagos NV4.86-286.68%
SRPTSarepta Therapeutics Inc4.88-287.57%
ABEOAbeona Therapeutics Inc5.39-306.99%
ABUSArbutus Biopharma Corp5.60-314.99%
ZVRAZevra Therapeutics Inc5.89-326.19%
SPROSpero Therapeutics Inc6.23-339.30%
CGENCompugen Ltd6.31-342.59%
RIGLRigel Pharmaceuticals6.87-364.03%
SLXNSilexion Therapeutics Corp7.30-380.32%
OMEROmeros Corporation9.26-455.73%
AUPHAurinia Pharmaceuticals Inc9.58-468.26%
PLXProtalix BioTherapeutics Inc10.89-518.44%
ACADAcadia Pharmaceuticals Inc11.73-550.62%
TBPHTheravance Biopharma Inc12.26-571.12%
ADMAAdma Biologics Inc12.42-577.11%
HRMYHarmony Biosciences Holdings Inc13.82-630.98%
SABSSAB Biotherapeutics Inc14.14-643.12%
NAGENiagen Bioscience Inc14.82-669.32%
INCYIncyte Corp15.82-707.91%
REGNRegeneron Pharmaceuticals Inc15.86-709.22%
PBYIPuma Biotechnology Inc17.32-765.28%
CPRXCatalyst Pharmaceuticals Inc17.44-770.03%
EXELExelixis Inc17.54-773.82%
TGTXTG Therapeutics Inc18.97-828.69%
MDXGMimedx Group Inc20.55-889.64%
XOMAXOMA Royalty Corp22.87-978.88%
ARGXArgen X SE24.30-1033.57%
CTMXCytomX Therapeutics Inc24.82-1053.67%
XOMAOXOMA Royalty Corp25.34-1073.79%
HALOHalozyme Therapeutics Inc25.62-1084.51%
XOMAPXOMA Royalty Corp25.67-1086.29%
VRTXVertex Pharmaceuticals Inc27.99-1175.61%
RPRXRoyalty Pharma plc - Class A28.69-1202.22%
SLNOSoleno Therapeutics Inc29.02-1214.82%
ASNDAscendis Pharma A/S30.09-1255.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1556.64%
APLSApellis Pharmaceuticals Inc39.02-1599.26%
BMRNBiomarin Pharmaceutical Inc42.21-1721.85%
KRYSKrystal Biotech Inc45.34-1842.17%
ONCBeiGene Ltd69.54-2771.86%
PHARPharming Group N.V.75.03-2982.61%
TECHBio-Techne Corp101.96-4017.42%
VCELVericel Corp109.92-4323.37%
ALNYAlnylam Pharmaceuticals Inc117.96-4632.42%
GMABGenmab140.29-5490.22%
TLXTelix Pharmaceuticals Ltd162.15-6330.19%
CORTCorcept Therapeutics Inc212.86-8278.36%